Related Articles
Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: A randomized control trial
Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance
Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents
Effect of branched‑chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients
Branched-chain amino acid supplements reduced ascites and increased the quality of life in a patient with liver cirrhosis: A case report